Vision Shopsters: Pipeline Insight: Osteoporosis - Bone building drugs become the heart of the pipeline
Introduction
Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Across the seven major markets, sales for osteoporosis drugs grew with a compound annual growth rate (CAGR) of 2.0% from 2005 to $6.9 billion in 2009. Nonetheless, several promising pipeline drugs will help the market resume growth.
Scope
*Patient potential analysis across the seven major markets and BRIC nations (Brazil, Russia, India, and China).
*Review of the key clinical and environmental unmet needs supported by insight from key opinion leaders across the US, Europe and Japan.
*Analysis of target product profile for an osteoporosis drug.
*R&D pipeline analysis with detailed profiles and forecasts of key agents, including Amgen's Prolia (denosumab) and Merck's odanacatib.
Highlights
Osteoporosis prevalence is expected to increase due to the general aging population. By 2020, the total male and female osteoporosis population is forecast to increase by 16.0% from 168 million in 2010 to reach 188 million patients across the seven major markets.
Despite some long-term safety and cost concerns, Prolia will become the osteoporosis market leader by 2019, but will not achieve blockbuster sales. Moreover, its position will be threatened should odanacatib show a superior clinical profile.
Over the forecast period, three new anabolic drugs are due to launch. These will have to compete on cost, efficacy and safety with the class leader Forteo (teriparatide, Eli Lilly). While these drugs will address some unmet needs, early clinical data suggests that more potent drugs such Amgen's antisclerostin may dominate the market in the future.
Reasons to Purchase
*Understand patient population dynamics
*Gain insight into shortcomings of current osteoporosis treatment and to what extent pipeline drugs will address these unmet clinical needs.
*Identify licensing opportunities based on company portfolio and market needs.
To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/4615/Pipeline-Insight-Osteoporosis-Bone-building-drugs-become-the-heart-of-the-pipeline.html
Questions and Answers
Article Tags:
pipeline
,insight
,osteoporosis bone
,building drugs
,become
,heart pipeline
,market research
,market research reports
,industry analysis
,business research
,business market research
,industry reports
,market reports
,worldwide reports
In USA, one of the leading brands that offer diverse and high quality products promoting proper hygiene is Difresh USA. If you are looking for the best opportunity to grow and have the opportunity for a new business Difresh USA can help you for they are looking for Exclusive Local Distributors
Getting clean and refresh doesn't sacrifice the place where you are for it should be a habit. Having a healthy body will allow you to do things right and good. And no matter where you are you should practice a healthy and proper hygiene even in little things you do.
Maintaining a healthy and proper hygiene badly needs products that are truly effective and could truly answer our need for this. No matter where we are and at anytime we want to get clean we basically need these products right away and only Difresh USA can supply these in a very easy way
The key reason why some firms thrive while some implode during an financial recession is still a puzzle to many people business-owning business owners. Some wrongly assume that all businesses should suffer via recessionary cycles. But the truth is that some companies are usually essentially recession-proof, and it is not necessarily because they are much larger, better known, or a lot more generously capitalized.
Companies like Arch Coal (ACI) and Massey Energy (MEE) watched his or her stock climbed.
This Westpac case study forms part of Datamonitor's Financial Services Consumer Insights series, as part of which best practice in specific areas of FS are highlighted.
The UK life and pension providers have realized the necessity of engaging with consumers and not just developing relationships with intermediaries in order to engage them with saving.
Utilities: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data
Water Utilities: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the Water Utilities industry in Brazil
Discuss this Article
